DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

11.74 -0.22 (-1.84%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLDX $11.74 -1.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.93
Previous Close $11.96
Daily Range $11.17 - $11.99
52-Week Range $10.11 - $32.82
Market Cap $1.2B
P/E Ratio -9.06
Dividend (Yield) $0.00 (0.0%)
Volume 1,728,490
Average Daily Volume 1,676,053
Current FY EPS -$1.37




Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website:

News & Commentary Rss Feed

Why Celldex Shares Jumped 12% Friday

Comments at an industry conference last week led to a rally in Celldex Therapeutics shares last Friday.

5 Top Stocks to Buy in October

Looking to invest new money in the stock market this month? Here are five intriguing opportunities from various sectors of the market.

Why Biotech Took a Beating Today

What goes up must come down.

Is Celldex a Bargain After Losing a Third of Its Value Last Month?

A promising brain cancer drug could make Celldex Therapeutics an intriguing clinical-stage biotech to buy.

Healthcare Insider Roundup: Acadia Pharmaceuticals Is Just Getting Started, And More

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

The Numbers Behind Biotech's Horrible, No Good, Awful August

Insider Trading Alert - SWI, CLDX And CLGX Traded By Insiders

Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session

Perilous Reversal Stock: Celldex Therapeutics (CLDX)

See More CLDX News...

CLDX's Top Competitors

CLDX $11.74 (-1.84%)
Current stock: CLDX
AMGN $149.90 (1.25%)
Current stock: AMGN
GILD $100.81 (0.54%)
Current stock: GILD
BIIB $279.88 (0.23%)
Current stock: BIIB